• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[MTN] [점프업바이오] 큐로셀, ‘안발셀’ 임상서 효능 입증…”올해 품목허가 목표”

2024/03/18

[점프업바이오] 큐로셀, ‘안발셀’ 임상서 효능 입증…”올해 품목허가 목표” (mtn.co.kr)

Prev[비즈워치] 국내 첫 CAR-T 개발 성큼…큐로셀, ‘넥스트 스텝’은
Next[한국경제TV] 김건수 큐로셀 대표 “국산 CAR-T 치료제 상업화 머지않았다” [현장에서 만난 CEO]
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.